Request a Quote

Cyprotex Highlights - November 2022

2022 Header

Cyprotex is delighted to announce the publication of a review article in Expert Opinion on Drug Metabolism and Toxicology. The article, authored by our Drug Transporter Sciences team, is entitled ‘Studying the Right Transporter at the Right Time: An In Vitro Strategy for Assessing Drug-Drug Interaction Risk During Drug Discovery and Development’.

Read the article

Cyprotex recently presented the poster ‘Comparing Basic Static Models for Predicting Clinical CYP3A4 Induction Risk’ at the 2022 Joint DMDG/GMP/SPS conference in Amsterdam.

Read the poster here:

Read the poster

Join our experts Ralf Geiben Lynn, Chris Strock, Sravani Adusumalli, Anu Marahatta and Li Li at the NEDMDG in Cambridge, MA on the 5th December.

Click here to arrange a meeting with one of our team:

Arrange a meeting

Read the latest news from parent company, Evotec:

  • Evotec, CDP Venture Capital, and Angelini Ventures launch "Extend", a new BRIDGE partnership with leading Italian academic institutions
  • Just - Evotec Biologics wins a 2022 CPhI Pharma Award for its flexible cGMP biomanufacturing plant J.POD®
  • Evotec completes the acquisition of Central Glass Germany

Read the press releases

Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:

Read the blog

Contact us


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file